A mathematical model to estimate global hepatitis B disease burden and vaccination impact
- PMID: 16249217
- DOI: 10.1093/ije/dyi206
A mathematical model to estimate global hepatitis B disease burden and vaccination impact
Abstract
Background: Limited data are available regarding global hepatitis B virus (HBV)-related morbidity and mortality and potential reduction in disease burden from hepatitis B vaccination.
Methods: A model was developed to calculate the age-specific risk of acquiring HBV infection, acute hepatitis B (illness and death), and progression to chronic HBV infection. HBV-related deaths among chronically infected persons were determined from HBV-related cirrhosis and hepatocellular carcinoma (HCC) mortality curves, adjusted for background mortality. The effect of hepatitis B vaccination was calculated from vaccine efficacy and vaccination series coverage, with and without administration of the first dose of vaccine within 24 h of birth (i.e. birth dose) to prevent perinatal HBV infection.
Results: For the year 2000, the model estimated 620,000 persons died worldwide from HBV-related causes: 580,000 (94%) from chronic infection-related cirrhosis and HCC and 40,000 (6%) from acute hepatitis B. In the surviving birth cohort for the year 2000, the model estimated that without vaccination, 64.8 million would become HBV-infected and 1.4 million would die from HBV-related disease. Infections acquired during the perinatal period, in early childhood (<5 years old), and > or = 5 years of age accounted for 21, 48, and 31% of deaths, respectively. Routine infant hepatitis B vaccination, with 90% coverage and the first dose administered at birth would prevent 84% of global HBV-related deaths.
Conclusion: Globally, most HBV-related deaths result from the chronic sequelae of infection acquired in the perinatal and early childhood periods. Inclusion of hepatitis B vaccine into national infant immunization programs could prevent >80% of HBV-related deaths.
Similar articles
-
Hepatitis C and hepatitis B-related mortality in Spain.Eur J Gastroenterol Hepatol. 2009 Aug;21(8):895-901. doi: 10.1097/MEG.0b013e328313139d. Eur J Gastroenterol Hepatol. 2009. PMID: 19357523 Review.
-
Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.MMWR Morb Mortal Wkly Rep. 2007 May 11;56(18):441-5. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17495790
-
Prevention of hepatocellular carcinoma in hepatitis B virus infection.J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. J Gastroenterol Hepatol. 2009. PMID: 19702903 Review.
-
Implementation of newborn hepatitis B vaccination--worldwide, 2006.MMWR Morb Mortal Wkly Rep. 2008 Nov 21;57(46):1249-52. MMWR Morb Mortal Wkly Rep. 2008. PMID: 19023261
-
Rocks along the road to the control of HBV and HCC.Ann Epidemiol. 2009 Apr;19(4):231-4. doi: 10.1016/j.annepidem.2009.01.017. Ann Epidemiol. 2009. PMID: 19344859 Review.
Cited by
-
Hepatitis B Vaccine: Four Decades on.Vaccines (Basel). 2024 Apr 18;12(4):439. doi: 10.3390/vaccines12040439. Vaccines (Basel). 2024. PMID: 38675820 Free PMC article. Review.
-
Change in Rates of HBsAg and Anti-HBs in Şırnak 20 Years After Introduction of Hepatitis B Vaccine into Routine Infant Immunization Program.Infect Dis Clin Microbiol. 2023 Jun 23;5(2):153-157. doi: 10.36519/idcm.2023.231. eCollection 2023 Jun. Infect Dis Clin Microbiol. 2023. PMID: 38633007 Free PMC article.
-
Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future.J Clin Med. 2024 Apr 2;13(7):2055. doi: 10.3390/jcm13072055. J Clin Med. 2024. PMID: 38610820 Free PMC article. Review.
-
The Microbiome Matters: Its Impact on Cancer Development and Therapeutic Responses.J Microbiol. 2024 Mar;62(3):137-152. doi: 10.1007/s12275-024-00110-7. Epub 2024 Apr 8. J Microbiol. 2024. PMID: 38587593 Review.
-
Screening of hepatitis B and C viral infection, recognition of risk factors, and immunization of patients against hepatitis B virus: a module developed for effective hepatitis control.Front Public Health. 2023 Nov 23;11:1269209. doi: 10.3389/fpubh.2023.1269209. eCollection 2023. Front Public Health. 2023. PMID: 38106902 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical